NEW YORK (GenomeWeb News) – Bio-Reference Laboratories today reported that its first quarter revenues grew 12 percent, as the firm noted plans to expand its GeneDx business.

The Elmwood Park, NJ-based clinical lab firm reported revenues of $181.3 million for the three months ended January 31, up from $161.3 million for the first quarter of 2013. It beat the consensus Wall Street estimate of $171.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.